DUBLIN, Sept. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its ...

The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...

The FDA has approved the latest automated artificial pancreas system from Medtronic, the MiniMed 770G, for adults and children with Type 1 diabetes as young as 2 years old. This makes the hybrid, ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...

Knoxville-area mom Crystal had always been diligent with the health of her two sons. Now teens, they’re both active with hearty, and mostly healthy, appetites. So when her younger son, Landyn, was ...

Type I Diabetes is the most common type of diabetes in children, impacting about 1 in 400 children in the US according to the American Diabetes Association. Children diagnosed with Type 1 diabetes ...

Medtronic’s MiniMed 770G System has landed FDA clearance for its hybrid closed-loop system, marking the first time an automated insulin delivery system was greenlighted for young children with Type 1 ...

A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday. Affecting all lots, serial numbers, ...

A Brisbane diabetes patient has become the first in the world to be treated with a “life-changing” new insulin pump system. The pump, which is the only technology of its type in Australia, measures ...

Please provide your email address to receive an email when new articles are posted on . All Medtronic MiniMed 600 and 700 series insulin pumps have been recalled due to an increased risk for short ...

DUBLIN, June 23, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific ...